ACET Aceto Corporation

The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Aceto Corporation

NEW YORK--(BUSINESS WIRE)--

The Klein Law Firm announces the commencement of an investigation of Aceto Corporation (NASDAQGS: ACET) concerning possible violations of federal securities laws.

Aceto issued a press release on April 18, 2018, announcing that “the financial guidance issued on February 1, 2018, should no longer be relied upon.” The Company also announced that it anticipated recording “non-cash intangible asset impairment charges, including goodwill, in the range of $230 million to $260 million on certain currently marketed and pipeline generic products as a result of continued intense competitive and pricing pressures.” Following this news, shares of Aceto fell from a close of $7.40 on April 18, 2018, to a close of $2.66 on April 19, 2018.

If you suffered a loss in Aceto and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kkclasslaw.com/ACET-Info-Request-Form-294.

Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

EN
27/04/2018

Underlying

ACETAceto Corporation

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Aceto Corporation

MarketLine Department
  • MarketLine Department
EUR 151.67
ACET Aceto Corporati...

Disproquima SA - Company Profile and SWOT Analysis

Summary Disproquima SA - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Disproquima SA (Disproquima) is a marketer and distributor of wide range of functional ingredients. The company's product portfolio includes active pharmaceutical ingredients, vitamins and minerals, anti...

ACET ACETO CORPORATION
11/23/24 November 23, 2024 1 EN
Free Trial
ACET Aceto Corporati...

Adicet Bio Inc: 2 directors

A director at Adicet Bio Inc bought 5,000 shares at 2.400USD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...

ACET ACETO CORPORATION
07/01/23 July 1, 2023 1 EN
 PRESS RELEASE
Free
ACET Aceto Corporati...

ACETO Completes the Sale of Its Chemicals Business Assets

ACETO Completes the Sale of Its Chemicals Business Assets PORT WASHINGTON, N.Y., April 30, 2019 (GLOBE NEWSWIRE) -- ACETO Corporation (OTC: ACETQ) announced today that it has completed the previously disclosed sale of its chemicals business assets to an affiliate of New Mountain Capital, a leading growth-oriented investment firm with over $20 billion in assets under management. The purchase price paid in the transaction consisted of cash plus the payment of cure costs and the assumption of certain liabilities.  ACETO used a portion of the proceeds from the transaction to repay 100% of ...

April 30, 2019 1 EN
 PRESS RELEASE
Free
ACET Aceto Corporati...

ACETO to Sell its Chemicals Business Assets to New Mountain Capital

ACETO to Sell its Chemicals Business Assets to New Mountain Capital PORT WASHINGTON, N.Y., April 15, 2019 (GLOBE NEWSWIRE) -- ACETO Corporation (OTC: ACETQ), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that it has agreed to sell its chemicals business assets to an affiliate of New Mountain Capital (“NMC”), a leading growth-oriented investment firm with over $20 billion in assets under management. The asset purchase agreement was entered into following ...

April 15, 2019 1 EN
 PRESS RELEASE
Free
ACET Aceto Corporati...

ACETO Receives Court Approval of “Stalking Horse” Agreement to Sel...

ACETO Receives Court Approval of “Stalking Horse” Agreement to Sell Rising Pharmaceuticals to Shore Suven Pharma, Inc. PORT WASHINGTON, N.Y., April 12, 2019 (GLOBE NEWSWIRE) -- ACETO Corporation (OTC: ACETQ), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that it has received approval from the U.S. Bankruptcy Court  to sell the assets of Rising Pharmaceuticals and Rising’s subsidiaries to Shore Suven Pharma, Inc. for gross cash proceeds of $15 million, plu...

April 12, 2019 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch